Iovance Biotherapeutics Inc. (IOVA)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
MHR Fund Management

Mark Rachesky

19,997,103 $162,576,447 17.76%
2.
Perceptive Advisors

Joseph Edelman

11,979,415 $97,392,643 +1% 2.17%
3.
VenBio Select Advisor

Kurt Von Emster

6,700,000 $54,471,000 0.75%
4.
OrbiMed Advisors

Samuel Isaly

4,707,458 $38,271,634 0.76%
5. 3,926,159 $31,919,673 -13% 0.05%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$9.15 250,000 Director 320,150 2024-02-20 Filing
$9.15 32,000 Director 54,000 2024-02-20 Filing
$9.15 5,000,000 Director 28,067,333 2024-02-20 Filing
$5.56 10,000 Director 248,633 2023-09-18 Filing
$5.30 5,000,000 Director 23,067,333 2023-09-15 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$8.71 20,500 Director 100,000 2016-08-25 Filing
$9.10 33,500 Director 120,500 2016-08-24 Filing
$9.11 54,000 Director 100,000 2016-08-22 Filing
$7.13 16,500 Director 154,000 2015-09-08 Filing
$6.84 16,000 Director 170,500 2015-09-04 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 22,812,820 $185,468,227 0%
2. 19,071,756 $155,053,376 0%
3. 16,424,388 $133,530,274 0%
4. 5,263,309 $42,790,702 0.04%
5. 5,037,098 $40,956,054 0%
News See All